Literature DB >> 14679155

Cell cycle checkpoint function in bladder cancer.

Sharon C Doherty1, Stephanie R McKeown, Valerie McKelvey-Martin, C Stephen Downes, Anthony Atala, James J Yoo, Dennis A Simpson, William K Kaufmann.   

Abstract

BACKGROUND: Cell cycle checkpoints function to maintain genetic stability by providing additional time for repair of DNA damage and completion of events that are necessary for accurate cell division. Some checkpoints, such as the DNA damage G1 checkpoint, are dependent on p53, whereas other checkpoints, such as the decatenation G(2) checkpoint, are not. Because bladder transitional cell carcinomas (TCCs) often contain numerous chromosomal aberrations and appear to have highly unstable genomes, we analyzed cell cycle checkpoint functions in a panel of TCC lines.
METHODS: Cell cycle arrest was induced in normal human fibroblasts (NHF1-hTERT) and normal human uroepithelial cells (HUCs), and TCC lines and checkpoint functions were quantified using flow cytometry and fluorescence microscopy. The inducers and checkpoints were ionizing radiation (i.e., DNA damage) (G1 and G2 checkpoints), the mitotic inhibitor colcemid (polyploidy checkpoint), or the topoisomerase II catalytic inhibitor ICRF-193 (decatenation G2 checkpoint). Four of the five TCC lines expressed mutant p53.
RESULTS: HUCs had an effective G1 checkpoint response to ionizing radiation, with 68% of cells inhibited from moving from G1 into S phase. By contrast, G1 checkpoint function was severely attenuated (<15% inhibition) in three of the five TCC lines and moderately attenuated (<50% inhibition) in the other two lines. NHF1-hTERT had an effective polyploidy checkpoint response, but three of five TCC lines were defective in this checkpoint. HUCs had effective ionizing radiation and decatenation G2 checkpoint responses. All TCC lines had a relatively effective G2 checkpoint response to DNA damage, although the responses of two of the TCC lines were moderately attenuated relative to HUCs. All TCC lines had a severe defect in the decatenation G2 checkpoint response.
CONCLUSION: Bladder TCC lines have defective cell cycle checkpoint functions, suggesting that the p53-independent decatenation G2 checkpoint may cooperate with the p53-dependent G1 checkpoints to preserve chromosomal stability and suppress bladder carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14679155     DOI: 10.1093/jnci/djg120

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  31 in total

1.  Urolithins impair cell proliferation, arrest the cell cycle and induce apoptosis in UMUC3 bladder cancer cells.

Authors:  Joana Liberal; Anália Carmo; Célia Gomes; Maria Teresa Cruz; Maria Teresa Batista
Journal:  Invest New Drugs       Date:  2017-06-20       Impact factor: 3.850

2.  Revised genetic requirements for the decatenation G2 checkpoint: the role of ATM.

Authors:  Jacquelyn J Bower; Yingchun Zhou; Tong Zhou; Dennis A Simpson; Sonnet J Arlander; Richard S Paules; Marila Cordeiro-Stone; William K Kaufmann
Journal:  Cell Cycle       Date:  2010-04-15       Impact factor: 4.534

3.  A dominant interfering Bub1 mutant is insufficient to induce or alter thymic tumorigenesis in vivo, even in a sensitized genetic background.

Authors:  Dale O Cowley; Ginger W Muse; Terry Van Dyke
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

4.  Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling.

Authors:  J J Bower; G F Karaca; Y Zhou; D A Simpson; M Cordeiro-Stone; W K Kaufmann
Journal:  Oncogene       Date:  2010-06-21       Impact factor: 9.867

5.  Topoisomerase IIalpha controls the decatenation checkpoint.

Authors:  Kuntian Luo; Jian Yuan; Junjie Chen; Zhenkun Lou
Journal:  Nat Cell Biol       Date:  2008-12-21       Impact factor: 28.824

6.  Metnase mediates chromosome decatenation in acute leukemia cells.

Authors:  Justin Wray; Elizabeth A Williamson; Sheema Sheema; Suk-Hee Lee; Edward Libby; Cheryl L Willman; Jac A Nickoloff; Robert Hromas
Journal:  Blood       Date:  2009-05-20       Impact factor: 22.113

7.  Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression.

Authors:  William K Kaufmann; Kathleen R Nevis; Pingping Qu; Joseph G Ibrahim; Tong Zhou; Yingchun Zhou; Dennis A Simpson; Jennifer Helms-Deaton; Marila Cordeiro-Stone; Dominic T Moore; Nancy E Thomas; Honglin Hao; Zhi Liu; Janiel M Shields; Glynis A Scott; Norman E Sharpless
Journal:  J Invest Dermatol       Date:  2007-06-28       Impact factor: 8.551

8.  Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53.

Authors:  Yaxiong Tang; Anne R Simoneau; Jun Xie; Babbak Shahandeh; Xiaolin Zi
Journal:  Cancer Prev Res (Phila)       Date:  2008-11

9.  A predictive mathematical model of the DNA damage G2 checkpoint.

Authors:  Kevin J Kesseler; Michael L Blinov; Timothy C Elston; William K Kaufmann; Dennis A Simpson
Journal:  J Theor Biol       Date:  2012-12-22       Impact factor: 2.691

10.  Knockdown of SLBP results in nuclear retention of histone mRNA.

Authors:  Kelly D Sullivan; Thomas E Mullen; William F Marzluff; Eric J Wagner
Journal:  RNA       Date:  2009-01-20       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.